[go: up one dir, main page]

HK1126964A - Immediate-release tablet formulations of a thrombin receptor antagonist - Google Patents

Immediate-release tablet formulations of a thrombin receptor antagonist Download PDF

Info

Publication number
HK1126964A
HK1126964A HK09106181.7A HK09106181A HK1126964A HK 1126964 A HK1126964 A HK 1126964A HK 09106181 A HK09106181 A HK 09106181A HK 1126964 A HK1126964 A HK 1126964A
Authority
HK
Hong Kong
Prior art keywords
immediate
receptor antagonist
release tablet
tablet formulations
thrombin receptor
Prior art date
Application number
HK09106181.7A
Other languages
Chinese (zh)
Inventor
Rajan Gupta
Suliman Chawdry
Srinivas S. Duggirala
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of HK1126964A publication Critical patent/HK1126964A/en

Links

HK09106181.7A 2006-06-30 2007-06-29 Immediate-release tablet formulations of a thrombin receptor antagonist HK1126964A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US817821P 2006-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK12113532.4A Division HK1172571A (en) 2006-06-30 2009-07-09 Immediate-release tablet formulations of a thrombin receptor antagonist

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK12113532.4A Addition HK1172571A (en) 2006-06-30 2009-07-09 Immediate-release tablet formulations of a thrombin receptor antagonist

Publications (1)

Publication Number Publication Date
HK1126964A true HK1126964A (en) 2009-09-18

Family

ID=

Similar Documents

Publication Publication Date Title
ZA200900350B (en) Immediate-release tablet formulations of a thrombin receptor antagonist
HUS2100003I1 (en) Pharmaceutical combinations of an angiotensin receptor antagonist and a nep inhibitor
HUS2400046I1 (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
IL198869A0 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A PDGFRa ANTAGONIST
AU2013257508A1 (en) Pharmaceutical compositions
ZA200810164B (en) Sustained release pharmaceutical dosage form containing phenylphrine
PL2034970T3 (en) Sustained release pharmaceutical formulation comprising phenylephrine
IL198780A0 (en) Pharmaceutical formulation comprising neurokinin antagonist
ZA200902592B (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
EP2211843B8 (en) Pharmaceutical moire pill
GB2458593C2 (en) Anthelmintic tablet formulations
HK1126964A (en) Immediate-release tablet formulations of a thrombin receptor antagonist
GB0605104D0 (en) Tablet dispenser
GB0608465D0 (en) Tablet dispenser
HK1126985A (en) Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
HK1138761A (en) Pharmaceutical formulation comprising neurokinin antagonist
AU2007905661A0 (en) Controlled-release pharmaceutical formulation
HK1121388A (en) Sustained release pharmaceutical dosage form containing phenylephrine
HK1134437A (en) Multiple unit tablet compositions of benzimidazole compounds
ZA200902164B (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a PDE5 inhibitor
HK1131347A (en) Solid pharmaceutical dosage formulations
HK1118726A (en) Pharmaceutical formulations
HK1117423A (en) Pharmaceutical formulations
HK1133832A (en) Pharmaceutical formulations
HK1118725A (en) Pharmaceutical formulations